Moreover, a significant increase of TgAb and TPOAb titers was observed in Group 1 patients versus controls (Table 1).Considering the behavior related to the kind of treatment, we found a non-significant higher prevalence of APA and AHA in patients on anti-PD-L1 therapy (Table 2). The gene discussed is CD274; the disease is autoimmune hemolytic anemia.